[HTML][HTML] Therapeutic targets in idiopathic pulmonary fibrosis
M Kolb, F Bonella, L Wollin - Respiratory medicine, 2017 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal interstitial lung
disease. After many drugs failed in clinical trials, improvements in the understanding of the …
disease. After many drugs failed in clinical trials, improvements in the understanding of the …
[引用][C] Therapeutic targets in idiopathic pulmonary fibrosis
M Kolb, F Bonella, L Wollin - Respiratory Medicine, 2017 - cir.nii.ac.jp
Therapeutic targets in idiopathic pulmonary fibrosis | CiNii Research CiNii 国立情報学研究所
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
[HTML][HTML] Therapeutic targets in idiopathic pulmonary fibrosis
M Kolb, F Bonella, L Wollin - Respiratory Medicine, 2017 - resmedjournal.com
Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal interstitial lung
disease. After many drugs failed in clinical trials, improvements in the understanding of the …
disease. After many drugs failed in clinical trials, improvements in the understanding of the …
Therapeutic targets in idiopathic pulmonary fibrosis
M Kolb, F Bonella, L Wollin - Respiratory medicine, 2017 - pubmed.ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal interstitial lung
disease. After many drugs failed in clinical trials, improvements in the understanding of the …
disease. After many drugs failed in clinical trials, improvements in the understanding of the …
Therapeutic targets in idiopathic pulmonary fibrosis.
M Kolb, F Bonella, L Wollin - Respiratory Medicine, 2017 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal interstitial lung
disease. After many drugs failed in clinical trials, improvements in the understanding of the …
disease. After many drugs failed in clinical trials, improvements in the understanding of the …